Skip to content

Inspection Record

Bonita Pharmaceuticals Inc. — Health Canada Inspection Findings

Health CanadaInspected 2026-08-13 6 findingsEquipment and facilityStability and storageRegulatory reporting and change controlOther quality systemDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

2Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

3Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

4Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

5Other quality system

The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.

6Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the Health Canada inspection on 2026-08-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Bonita Pharmaceuticals Inc. company profile — full historyAll Health Canada findings Health Canada documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.